
This study evaluated the role of nuclear-restricted protein/brain (NRP/B) in brain tumor development. The researchers found abnormal expression of NRP/B in human brain tumor cells derived from astrocytes. Mutations in the NRP/B gene were detected in brain tumor cell lines and primary malignant brain tumor tissues. These mutations, particularly in the Kelch domains of NRP/B, were associated with increased activation of ERK, promoting cell proliferation and inhibiting apoptosis. The mutations also affected the binding affinity of NRP/B to actin, impacting nuclear cytoskeleton dynamics. The findings suggest that NRP/B gene alterations and mutations contribute to brain tumorigenesis through various cellular mechanisms.
Like
Save
Share